MINIEYE (02431) signs unmanned vehicle sales contract with Ideas Group.
The company Yojia Innovation (02431) announced that it has recently entered into a sales contract with Ideas Group Pty Ltd (Ideas Group). According to the contract, Ideas Group will purchase a batch of 1,600 small bamboo unmanned vehicles from the group, mainly deployed in Australia and Southeast Asia.
MINIEYE (02431) announced that the company has recently signed a sales contract with Ideas Group Pty Ltd (Ideas Group). According to the contract, Ideas Group will purchase a batch of MiniEYE unmanned vehicles from the group, with a total quantity of 1,600 vehicles, mainly deployed in Australia and Southeast Asia.
This contract reflects the high recognition of overseas customers for the group's autonomous driving technology, product maturity, and commercial solutions, marking an important milestone for the group's unmanned logistics vehicle business to achieve large-scale deployment overseas.
Ideas Group's procurement is mainly targeted at its target markets in Australia and Southeast Asia. Signing this contract will help the group quickly establish a solid presence in Australia and Southeast Asia, effectively expand its overseas market footprint, and enhance the international influence and competitiveness of the group's unmanned vehicle products.
The board believes that signing this contract will further strengthen the group's layout in the overseas unmanned logistics market, enhance the international influence and competitiveness of the group's unmanned vehicle products, and accelerate the large-scale commercial application of the group's autonomous driving technology in overseas markets. This will also help the group accumulate valuable overseas operation experience, expand its global customer base and market channels, and lay a solid foundation for the group's long-term development in the global smart logistics and autonomous driving industry, in line with the group's long-term development strategy and the overall interests of the company and shareholders.
Related Articles

Yue Yuen Industries (00551) total comprehensive operating income for the first three months decreased by 2.2% year-on-year to 1.985 billion US dollars.

Jiangsu Hengrui Pharmaceuticals (600276.SH): HRS-5765 tablets have obtained the drug clinical trial approval letter.

Jiangsu Hengrui Pharmaceuticals (01276): HRS-5765 tablets obtain drug clinical trial approval notification.
Yue Yuen Industries (00551) total comprehensive operating income for the first three months decreased by 2.2% year-on-year to 1.985 billion US dollars.

Jiangsu Hengrui Pharmaceuticals (600276.SH): HRS-5765 tablets have obtained the drug clinical trial approval letter.

Jiangsu Hengrui Pharmaceuticals (01276): HRS-5765 tablets obtain drug clinical trial approval notification.

RECOMMEND





